Actively Recruiting
Brain Blood Flow and Lactate in Non-obese and Obese Subjects
Led by University of Missouri-Columbia · Updated on 2025-11-26
24
Participants Needed
1
Research Sites
95 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Cerebral blood flow (CBF) is essential for maintaining brain health and function, as it ensures delivery oxygen and nutrients necessary to support neuronal activity. Reduced CBF can impair the brain's ability to meet its metabolic demands, leading to deficits in cognitive ability. Impairments in CBF are associated with cognitive decline and neurodegenerative disease such as Alzheimer's and dementia. Many factors influence CBF, but recently lactate has emerged as a key player. Blood glucose has long been considered the primary fuel for the brain, but emerging evidence indicates that lactate may be the preferred fuel for neurons, and lactate may become even more important under stressful conditions. Individuals with obesity often have impaired lactate metabolism resulting in higher resting blood lactate concentrations and reduced ability to clear lactate after a physiological stress. At the same time, it is known that exercise is a powerful intervention for improving lactate metabolism. Thus, this project seeks to investigate the role of lactate in brain blood flow in individuals with and without obesity as well as establish if short term exercise training (individuals with obesity only) will alter circulating lactate concentrations at rest and in response to exercise.
CONDITIONS
Official Title
Brain Blood Flow and Lactate in Non-obese and Obese Subjects
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Healthy adult men and women aged 18 to 45 years
- Body mass index (BMI) between 18 and 40 kg/m2
- Not pregnant and premenopausal with regular menstrual cycles
- Not breastfeeding
- Non-nicotine users
You will not qualify if you...
- Use of medications affecting sleep, autonomic control, blood lactate levels, metabolic or cardiovascular function (per investigator discretion)
- History of liver, kidney, lung, heart, neurological disease, stroke, neurovascular disease, bleeding or clotting disorders, sleep apnea or other sleep disorders
- Diagnosis of diabetes
- History of alcoholism or substance abuse
- Major cardiovascular event or surgery within the past three months
- Hypertension (blood pressure >140/90 mmHg or per investigator discretion)
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
University of Missouri
Columbia, Missouri, United States, 65211
Actively Recruiting
Research Team
M
Matt McDonald, MS
CONTACT
J
Jill Kanaley, PhD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here